[Bevacizumab/irinotecan. An active treatment for recurrent high grade gliomas: preliminary results of an ANOCEF Multicenter Study].
暂无分享,去创建一个
B. Chauffert | S. Taillibert | J. Honnorat | O. Chinot | P. Fumoleau | A. Desjardins | B. Guiu | L. Taillandier | P. Dietrich | J. Guillamo | S. Guiu | S. Cartalat‐Carel | K. Xuan | C. Deville | I. Catry-Thomas | J. Maire | A. Thiebaut | F. Capelle